Question 1

What is the catalog number for PRKCZ (Protein Kinase C zeta Type, nPKC-zeta, PKC2) (MaxLight 405) discontinued?

Accepted Answer

The catalog number for PRKCZ (Protein Kinase C zeta Type, nPKC-zeta, PKC2) (MaxLight 405) discontinued is 131812-ML405.

Question 2

What sizes are available for PRKCZ (Protein Kinase C zeta Type, nPKC-zeta, PKC2) (MaxLight 405) discontinued?

Accepted Answer

PRKCZ (Protein Kinase C zeta Type, nPKC-zeta, PKC2) (MaxLight 405) discontinued is available in the following size(s): 100 µL.

Question 3

Is PRKCZ (Protein Kinase C zeta Type, nPKC-zeta, PKC2) (MaxLight 405) discontinued in stock?

Accepted Answer

PRKCZ (Protein Kinase C zeta Type, nPKC-zeta, PKC2) (MaxLight 405) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Question 5

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

Question 6

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

PRKCZ (Protein Kinase C zeta Type, nPKC-zeta, PKC2) (MaxLight 405) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Anti-PC4/SUB1 Antibody Picoband® (APC Conjugate)

FOXA1 / HNF3A (FOXA1/1516), Biotin conjugate, 0.1mg/mL

CD19 (CVID3/429), CF488A conjugate, 0.1mg/mL

MyoD1 (Rhabdomyosarcoma Marker) (rMYD712), CF640R conjugate, 0.1mg/mL

Carbonic Anhydrase VIII (CPTC-CA8-2), 0.2mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF568 conjugate, 0.1mg/mL